These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1513932)

  • 21. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.
    Ravindran AV; Bialik RJ; Lapierre YD
    J Affect Disord; 1994 Jun; 31(2):111-7. PubMed ID: 8071473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of venlafaxine, trazodone, and placebo in major depression.
    Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
    J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dysthymic disorder and its treatment].
    Akiskal H
    Encephale; 1993 Jul; 19 Spec No 2():375-8. PubMed ID: 8281904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Speed of onset of action of the newer antidepressants--fluoxetine and bupropion.
    George MS; Lydiard RB
    Int Clin Psychopharmacol; 1991; 6(4):209-17. PubMed ID: 1840065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of major depression: is improvement enough?
    Ferrier IN
    J Clin Psychiatry; 1999; 60 Suppl 6():10-4. PubMed ID: 10235119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
    Cassano GB; Conti L; Dell'Osso L; Massimetti G
    Adv Biochem Psychopharmacol; 1982; 32():125-39. PubMed ID: 7046361
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled comparison of milnacipran and fluoxetine in major depression.
    Ansseau M; Papart P; Troisfontaines B; Bartholomé F; Bataille M; Charles G; Schittecatte M; Darimont P; Devoitille JM; De Wilde J
    Psychopharmacology (Berl); 1994 Feb; 114(1):131-7. PubMed ID: 7846195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.
    Kallepalli BR; Bhatara VS; Fogas BS; Tervo RC; Misra LK
    J Child Adolesc Psychopharmacol; 1997; 7(2):97-107. PubMed ID: 9334895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
    Gendall KA; Joyce PR; Mulder RT; Luty SE
    J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History of antidepressants: successes and failures.
    Kelwala S; Stanley M; Gershon S
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute stimulant response prediction of chronic trazodone effects.
    Little KY; Gay TL
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):815-24. PubMed ID: 8870066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 13():26-9. PubMed ID: 14552653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antidepressants--the serotonin reuptake inhibitors.
    Awad AG
    Psychiatr J Univ Ott; 1987 Mar; 12(1):31-4. PubMed ID: 2954176
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoamine oxidase inhibitors and atypical antidepressants.
    Salzman C
    Clin Geriatr Med; 1992 May; 8(2):335-48. PubMed ID: 1600483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study.
    Savarese M; Carnicelli M; Cardinali V; Mogavero MP; Federico F
    Arch Ital Biol; 2015; 153(2-3):231-8. PubMed ID: 26742677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine in borderline personality disorder.
    Norden MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):885-93. PubMed ID: 2813806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.